ASDAS A | ASDAS B | ASDAS C | ASDAS D | |
Included variables | BASDAI Q2 Patient global BASDAI Q6 Ln (CRP+1) √(ESR) | Patient global √(ESR) BASDAI Q3 BASDAI Q6 BASDAI Q2 | BASDAI Q2 Patient global BASDAI Q3 BASDAI Q6 Ln (CRP+1) | √(ESR) BASDAI Q2 Ln (CRP+1) BASDAI Q6 BASDAI Q1 |
Excluded variables | – | CRP | ESR | Patient global |
Items from ISSAS database | ||||
BASDAI | 0.67 | 0.80 | 0.75 | 0.68 |
Patient global | 0.72 | 0.76 | 0.75 | 0.63 |
BASFI | 0.60 | 0.65 | 0.62 | 0.60 |
CRP | 0.69 | 0.46 | 0.68 | 0.70 |
ESR | 0.71 | 0.68 | 0.49 | 0.72 |
Swollen joint count | 0.27 | 0.34 | 0.28 | 0.27 |
ASDAS, Ankylosing Spondylitis Disease Activity Score; BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; BASFI, Bath Ankylosing Spondylitis Functional Index; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; ISSAS, International Study on Starting TNF blocking agents in Ankylosing Spondylitis; Q, question; TNF, tumour necrosis factor.